Early detection and prevention remain central to reducing cancer incidence, morbidity, and mortality. This session explores advances in cancer screening, risk assessment, preventive strategies, early diagnostic approaches, and technologies aimed at identifying malignancies at their earliest and most treatable stages. It also considers genetic, environmental, behavioral, and population-level factors that influence cancer risk.
Abstract Scope and Participation
Abstracts are welcomed on cancer screening, early diagnosis, risk prediction, prevention, precancerous conditions, population screening programs, novel detection technologies, and related clinical or public-health approaches. Researchers, clinicians, epidemiologists, public-health professionals, and specialists involved in cancer prevention and early detection are encouraged to participate.







Title : Long-read sequencing reveals dynamic features of human malignancies
Jianhua Luo, University of Pittsburgh School of Medicine, United States
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States